# Effects of 4-AP on Functional SCI Recovery

> **NCT05447676** · EARLY_PHASE1 · UNKNOWN · sponsor: **Shirley Ryan AbilityLab** · enrollment: 44 (estimated)

## Conditions studied

- Spinal Cord Injury

## Interventions

- **DRUG:** Dalfampridine
- **OTHER:** Placebo drug
- **OTHER:** STDP stimulation
- **BEHAVIORAL:** Exercise training

## Key facts

- **NCT ID:** NCT05447676
- **Lead sponsor:** Shirley Ryan AbilityLab
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-30
- **Primary completion:** 2024-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2023-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05447676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05447676, "Effects of 4-AP on Functional SCI Recovery". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05447676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*